Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Clinical and Experimental Rheumatology
|
September 8, 2015
Cardiac abnormalities assessed by non-invasive techniques in patients with newly diagnosed idiopathic inflammatory myopathies
Louise Pyndt Diederichsen, Jane Angel Simonsen, Axel Cosmus Pyndt Diederichsen, et al.
Plos One
|
February 6, 2016
Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response
Tue Wenzel Kragstrup, Babak Jalilian, Kresten Krarup Keller, et al.
Arthritis Research & Therapy
|
March 13, 2016
The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression
Tue Wenzel Kragstrup, Stinne Ravn Greisen, Morten Aagaard Nielsen, et al.
Annals of the Rheumatic Diseases
|
February 4, 2012
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP
Merete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg, et al.
Frontiers in Immunology
|
March 31, 2022
The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings
Stinne R Greisen, Tue W Kragstrup, Jesper Skovhus Thomsen, et al.
Immunologic Research
|
June 21, 2015
Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci
Bjørn A Nexø, Palle Villesen, Kari K Nissen, et al.
Arthritis and Rheumatism
|
April 29, 2006
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study
Merete Lund Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
The Journal of Rheumatology
|
May 17, 2011
Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis
Anne F Christensen, Hanne Lindegaard, Kim Hørslev-Petersen, et al.
Annals of the Rheumatic Diseases
|
May 7, 2010
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial
Merete L Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
Annals of the Rheumatic Diseases
|
February 26, 2013
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial
Kim Hørslev-Petersen, Merete Lund Hetland, Peter Junker, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Clinical and Experimental Rheumatology
|
September 8, 2015
Cardiac abnormalities assessed by non-invasive techniques in patients with newly diagnosed idiopathic inflammatory myopathies
Louise Pyndt Diederichsen, Jane Angel Simonsen, Axel Cosmus Pyndt Diederichsen, et al.
Plos One
|
February 6, 2016
Changes in Soluble CD18 in Murine Autoimmune Arthritis and Rheumatoid Arthritis Reflect Disease Establishment and Treatment Response
Tue Wenzel Kragstrup, Babak Jalilian, Kresten Krarup Keller, et al.
Arthritis Research & Therapy
|
March 13, 2016
The interleukin-20 receptor axis in early rheumatoid arthritis: novel links between disease-associated autoantibodies and radiographic progression
Tue Wenzel Kragstrup, Stinne Ravn Greisen, Morten Aagaard Nielsen, et al.
Annals of the Rheumatic Diseases
|
February 4, 2012
Short- and long-term efficacy of intra-articular injections with betamethasone as part of a treat-to-target strategy in early rheumatoid arthritis: impact of joint area, repeated injections, MRI findings, anti-CCP, IgM-RF and CRP
Merete Lund Hetland, Mikkel Østergaard, Bo Ejbjerg, et al.
Frontiers in Immunology
|
March 31, 2022
The Programmed Death-1 Pathway Counter-Regulates Inflammation-Induced Osteoclast Activity in Clinical and Experimental Settings
Stinne R Greisen, Tue W Kragstrup, Jesper Skovhus Thomsen, et al.
Immunologic Research
|
June 21, 2015
Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci
Bjørn A Nexø, Palle Villesen, Kari K Nissen, et al.
Arthritis and Rheumatism
|
April 29, 2006
Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study
Merete Lund Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
The Journal of Rheumatology
|
May 17, 2011
Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis
Anne F Christensen, Hanne Lindegaard, Kim Hørslev-Petersen, et al.
Annals of the Rheumatic Diseases
|
May 7, 2010
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial
Merete L Hetland, Kristian Stengaard-Pedersen, Peter Junker, et al.
Annals of the Rheumatic Diseases
|
February 26, 2013
Adalimumab added to a treat-to-target strategy with methotrexate and intra-articular triamcinolone in early rheumatoid arthritis increased remission rates, function and quality of life. The OPERA Study: an investigator-initiated, randomised, double-blind, parallel-group, placebo-controlled trial
Kim Hørslev-Petersen, Merete Lund Hetland, Peter Junker, et al.
Page
of 8